Jagsonpal Pharmaceuticals Ltd Q1FY21 net profit higher at Rs. 2.52 crore

JAGSONPAL PHARMACEUTICALS LTD. has reported financial results for the period ended June 30, 2020.

Financial Results (Q1 FY 2020-21) - QoQ Comparison

The company has reported total income of Rs.32.43 crores during the period ended June 30, 2020 as compared to Rs.30.27 crores during the period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.2.52 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.1.55 crores for the period ended March 31, 2020.

The company has reported EPS of Rs.0.96 for the period ended June 30, 2020 as compared to Rs.0.59 for the period ended March 31, 2020.

Financials	Q1 FY2020-21	Q4 FY19-20	% Change
Total Income	₹ 32.43 crs	₹ 30.27 crs	7.14%
Net Profit	₹ 2.52 crs	₹ 1.55 crs	62.58%
EPS	₹ 0.96	₹ 0.59	62.71%

Financial Results (Q1 FY 2020-21) - YoY Comparison

The company has reported total income of Rs.32.43 crores during the period ended June 30, 2020 as compared to Rs.45.90 crores during the period ended June 30, 2019.

The company has posted net profit / (loss) of Rs.2.52 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.2 crores for the period ended June 30, 2019.

The company has reported EPS of Rs.0.96 for the period ended June 30, 2020 as compared to Rs.0.76 for the period ended June 30, 2019.

Financials	Q1 FY2020-21	Q1 FY2019-20	% Change
Total Income	₹ 32.43 crs	₹ 45.90 crs	-29.35%
Net Profit	₹ 2.52 crs	₹ 2 crs	26%
EPS	₹ 0.96	₹ 0.76	26.32%

Shares of JAGSONPAL PHARMACEUTICALS LTD. was last trading in BSE at Rs.37.3 as compared to the previous close of Rs. 38.3. The total number of shares traded during the day was 2758 in over 57 trades.

The stock hit an intraday high of Rs. 38.9 and intraday low of 36.85. The net turnover during the day was Rs. 103604.

Source : Equity Bulls

Keywords